Start Date
January 31, 2015
Primary Completion Date
July 31, 2016
Study Completion Date
July 31, 2016
GCS-100
3 mg GCS-100 IV push. All doses of study drug will be administered least once monthly for a total of 1 year with a follow-up 4 weeks after the last dose is administered.
Mountain Kidney and Hypertension Associates, PA, Asheville
Clinical Advancement Center, PLLC, San Antonio
Denver Nephrology, Denver
Southwest Clinical Research Institute, LLC, Tempe
California Institute of Renal Research, La Mesa
Lead Sponsor
La Jolla Pharmaceutical Company
INDUSTRY